Sign In
Buy ALXN
$182.50
+0 (+0%)
At Close: May 27, 2022
Alexion drops kidney disease program for drug that was part of $930M Achillion buyout last year
04:36pm, Thursday, 30'th Jul 2020
The company said in its 2Q earnings that it would halt development of ALXN2040 for C3 glomerulopathy, or C3G, citing the drug's lack of potency. However, it may develop a second, more potent drug from
What's Behind Alexion Pharmaceuticals' Strong Q2 Results
04:00pm, Thursday, 30'th Jul 2020
Alexion Pharmaceuticals (NASDAQ: ALXN) stock has been on a big roll over the last few months. Alexion announced a net loss in Q2 of $1.1 billion, or $4.84 per share, based on generally accepted acco
Alexion (ALXN) Beats on Q2 Earnings & Sales, Ups '20 Guidance
03:14pm, Thursday, 30'th Jul 2020
Alexion (ALXN) beats on earnings and sales in the second quarter of 2020.
Alexion Pharmaceuticals (ALXN) Beats Q2 Earnings and Revenue Estimates
02:55pm, Thursday, 30'th Jul 2020
Alexion (ALXN) delivered earnings and revenue surprises of 21.96% and 14.12%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Alexion Pharmaceuticals, Inc. (ALXN) CEO Ludwig Hantson on Q2 2020 Results - Earnings Call Transcript
01:50pm, Thursday, 30'th Jul 2020
Alexion Pharmaceuticals, Inc. (ALXN) CEO Ludwig Hantson on Q2 2020 Results - Earnings Call Transcript
What's Behind Alexion Pharmaceuticals' Strong Q2 Results
12:00pm, Thursday, 30'th Jul 2020
It wasn't the company's blockbuster drug Soliris this time around.
Recap: Alexion Pharmaceuticals Q2 Earnings
11:50am, Thursday, 30'th Jul 2020
Shares of Alexion Pharmaceuticals (NASDAQ:ALXN) rose 1.3% in pre-market trading after the company reported Q2 results.Quarterly Results Earnings per share increased 17.80% year over year to $3.11, whi
Alexion Pharmaceuticals, Inc. 2020 Q2 - Results - Earnings Call Presentation
11:22am, Thursday, 30'th Jul 2020
The following slide deck was published by Alexion Pharmaceuticals, Inc. in conjunction with their 2020 Q2 earnings call..
Alexion (ALXN) Beats on Q2 Earnings & Sales, Ups '20 Guidance
11:14am, Thursday, 30'th Jul 2020
Alexion (ALXN) beats on earnings and sales in the second quarter of 2020.
Alexion Pharmaceuticals (ALXN) Beats Q2 Earnings and Revenue Estimates
10:55am, Thursday, 30'th Jul 2020
Alexion (ALXN) delivered earnings and revenue surprises of 21.96% and 14.12%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Alexion Reports Second Quarter 2020 Results
10:30am, Thursday, 30'th Jul 2020
Alexion Reports Second Quarter 2020 Results
Alexion Pharmaceuticals Earnings Top; Big Biotech Raises Guidance
07:10am, Thursday, 30'th Jul 2020
Alexion Pharmaceuticals earnings and sales comfortably beat Q2 views. The biotech company also raised full-year guidance.
Alexion Reports Second Quarter 2020 Results
06:30am, Thursday, 30'th Jul 2020
BOSTON--(BUSINESS WIRE)--Alexion Reports Second Quarter 2020 Results
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 29)
Abbott Laboratories (NYSE: ABT)
ABIOMED, Inc. (NASDAQ: ABMD)
Adamis Pharmaceuticals Corp (NASDAQ: ADMP)
Annexon...
Why Earnings Season Could Be Great for Alexion (ALXN)
12:27pm, Wednesday, 29'th Jul 2020
Alexion (ALXN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
